Richmond, CA, United States of America

Peter Wing Yiu Chan


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Profile: Peter Wing Yiu Chan

Introduction

Peter Wing Yiu Chan is a distinguished inventor based in Richmond, California, with a focus on innovative biopharmaceutical constructs. With a total of two patents to his name, Chan is contributing significantly to advancements in targeted therapies that address critical receptors like EGFR and HER2.

Latest Patents

Chan's latest inventions include groundbreaking patents that enhance the capabilities of antigen-binding constructs. The first patent describes **monovalent antigen-binding constructs targeting EGFR and/or HER2**, which consist of antigen-binding polypeptides specifically designed to bind to these key receptors. The constructs feature a heterodimeric Fc domain that can be coupled to the antigen-binding polypeptide, providing not only methods for fabrication but also approaches for application in targeted therapies.

His second patent is on **bispecific HER2 and HER3 antigen-binding constructs**. This invention includes isolated bi-specific antibodies that contain two antigen-binding polypeptide constructs, effectively binding to both HER2 and HER3 receptors. The constructs comprise a Fab format and an scFv format, combined with an Fc domain made for dimerization, which is crucial for their therapeutic efficacy.

Career Highlights

Peter Wing Yiu Chan is currently associated with Zymeworks Inc., a company recognized for its innovative work in biopharmaceutical development. His contributions to enhancing targeted therapies demonstrate not only his technical skill but also his commitment to improving patient outcomes in the realm of oncology and other related fields.

Collaborations

Chan collaborates closely with other talented professionals in the field, including Gordon Yiu Kon Ng and Grant Raymond Wickman. These collaborations emphasize the team-oriented approach that characterizes innovation within Zymeworks Inc., fostering an environment where groundbreaking ideas can flourish and develop into transformative therapies.

Conclusion

Peter Wing Yiu Chan is a notable inventor whose patents reflect a deep commitment to advancing medical science through innovative biopharmaceutical constructs. His work is essential in the ongoing fight against diseases governed by specific cellular receptors, positioning him as a leading figure in the realm of targeted therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…